Centrus Reports Strong 2025 Results, Secures $900M HALEU Award, and Launches Domestic Centrifuge Manufacturing
LEU has more than doubled off its 52-week low of $49.4.
Summary
Centrus Energy reported solid 2025 financial results, highlighted by a significant increase in cash, and announced major strategic advancements including a $900 million HALEU production award and the launch of domestic centrifuge manufacturing.
Key Events · Earnings and Guidance · LEU
-
Strong Full Year 2025 Financial Results
Centrus reported 2025 full year revenue of $448.7 million, gross profit of $117.5 million, and net income of $77.8 million, all showing increases over the prior year. The company also significantly strengthened its balance sheet, increasing its unrestricted cash balance to $2.0 billion.
-
Secures $900 Million HALEU Production Award
The U.S. Department of Energy selected Centrus for a $900.0 million task order, subject to negotiation, to expand its Piketon, Ohio facility for commercial-scale production of High-Assay Low-Enriched Uranium (HALEU). This follows the company's prior announcements regarding expansion plans.
-
Launches Domestic Centrifuge Manufacturing
In December 2025, Centrus began domestic centrifuge manufacturing to support commercial LEU enrichment activities at its Piketon, Ohio facility, marking a strategic move to capitalize on its first-mover advantages in U.S.-owned uranium enrichment.
-
Substantial Backlog and Positive 2026 Outlook
The company reported a total backlog of $3.8 billion as of December 31, 2025, including $2.3 billion in contingent LEU sales contracts. For 2026, Centrus expects total revenue between $425 million and $475 million and plans significant capital deployment of $350 million to $500 million for its industrial build-out.
Analysis · LEU · Energy & Transportation
Centrus Energy reported solid financial results for 2025, with increased revenue, gross profit, and net income, alongside a substantial boost in its unrestricted cash balance to $2.0 billion. The filing highlights several highly significant strategic advancements, including the selection for a $900 million HALEU production award from the U.S. Department of Energy, which is a major contract relative to the company's size and solidifies its role in national energy security. Furthermore, the launch of domestic commercial centrifuge manufacturing marks a critical milestone in restoring America's uranium enrichment capabilities. The company's substantial $2.3 billion contingent LEU sales backlog and positive 2026 outlook, including significant capital deployment for industrial build-out, underscore its strong growth trajectory and strategic importance in the nuclear fuel market.
At the time of this filing, LEU was trading at $241.99 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $49.40 to $464.25. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.